Myelodysplastic neoplasm
Clinical trials for Myelodysplastic neoplasm explained in plain language.
Never miss a new study
Get alerted when new Myelodysplastic neoplasm trials appear
Sign up with your email to follow new studies for Myelodysplastic neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Platelet-Boosting drug help control a rare bone marrow disorder?
Disease control OngoingResearchers are observing how well eltrombopag works in adults with hypocellular myelodysplastic neoplasms, a bone marrow condition that lowers blood cell counts. The study follows patients in Italy who receive eltrombopag alone or with immunosuppressive therapy as part of routin…
Matched conditions: MYELODYSPLASTIC NEOPLASM
Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising blood cancer combo trial pulled before it even started
Disease control CancelledThis early-stage trial aimed to test a combination of two drugs—ASTX727 (already approved for some blood cancers) and ASTX029 (an experimental ERK inhibitor)—in adults with myelodysplastic syndromes (MDS) or related blood cancers that have a mutation in the RAS pathway. The goal …
Matched conditions: MYELODYSPLASTIC NEOPLASM
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC